Friday November 1, 2024 the Swedish market closes at 13.00. Denmark and Norway are open as usual.

AcuCort is a pharmaceutical company. The company has developed and commercializes the drug Zeqmelit®, which is an oral film based on the cortisone substance dexamethasone, for quick availability and relief in severe and acute allergic reactions, among other things. The goal is commercialization in the EU, USA and in selected key markets via licensees and distributors. The company has its headquarters in Lund.

Quotes for AcuCort AB

Right Now

+/-
0.002
%
0,22%
Latest
0.91
High
0.94
Low
0.842
Volume
494 205
Turnover (SEK)
453 633
Market Value (MSEK)
108,4
Time (Latest trade)

Board

CEO

  • Jonas Jönmark

Chairperson of the Board

  • Ebba Fåhraeus

Board

  • Alexandra Johnsson
  • Anna Eriksrud
  • Göran Tornling
  • Monica Wallter

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 22,69 22,69 2024-09-26
Aqilion AB 9,50 9,50 2024-09-26
Jan Sören Poulsen 5,19 5,19 2024-09-26
Zoya Invest AB 3,02 3,02 2024-09-26
Olle Florén med bolag 2,85 2,85 2024-09-26
Bengt Schager 1,70 1,70 2024-09-26
Nordnet Pensionsförsäkring 1,38 1,38 2024-09-26
Johan Thorell 1,31 1,31 2024-09-26
Berne Gilbert Okdah 1,15 1,15 2024-09-26
Handelsbanken Liv Försäkring AB 1,02 1,02 2024-09-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream